ATG4B and pS383/392-ATG4B serve as potential biomarkers and therapeutic targets of colorectal cancer

MLA

Wan-Hsiang Hu, et al. “ATG4B and PS383/392-ATG4B Serve as Potential Biomarkers and Therapeutic Targets of Colorectal Cancer.” Cancer Cell International, vol. 23, no. 1, Apr. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12935-023-02909-7.

APA

Wan-Hsiang Hu, Ting-Ting Liu, Pei-Feng Liu, Paul Morgan, I-Ling Lin, Wei-Lun Tsai, Yi-Yun Cheng, Ang-Tsen Hsieh, Tsung-Hui Hu, & Chih-Wen Shu. (2023). ATG4B and pS383/392-ATG4B serve as potential biomarkers and therapeutic targets of colorectal cancer. Cancer Cell International, 23(1), 1–17. https://doi.org/10.1186/s12935-023-02909-7

Chicago

Wan-Hsiang Hu, Ting-Ting Liu, Pei-Feng Liu, Paul Morgan, I-Ling Lin, Wei-Lun Tsai, Yi-Yun Cheng, Ang-Tsen Hsieh, Tsung-Hui Hu, and Chih-Wen Shu. 2023. “ATG4B and PS383/392-ATG4B Serve as Potential Biomarkers and Therapeutic Targets of Colorectal Cancer.” Cancer Cell International 23 (1): 1–17. doi:10.1186/s12935-023-02909-7.